Navi Mumbai, India

Viraf Vasania

This inventor holds 1 USPTO granted patent. Top assignee: Reliance Life Sciences Pvt. Ltd.. Active years: 2012.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Viraf Vasania: Innovator in Ocular Tissue Engineering

Introduction

Viraf Vasania is a prominent inventor based in Navi Mumbai, India. He has made significant contributions to the field of ocular tissue engineering, particularly through his innovative patent related to conjunctival tissue systems. His work aims to address critical challenges in restoring ocular surface impairments.

Latest Patents

Viraf Vasania holds a patent for a conjunctival tissue system, which includes conjunctival cells and stem cells. This tissue system is derived from isolated conjunctival tissue and is designed to restore ocular surface impairments caused by damaged or diseased conjunctiva. The system is generated using a simple single medium culture scheme and a support material, such as human amniotic membrane. This innovative approach is suitable for transplantation to treat the ocular surface of an eye affected by damage or disease.

Career Highlights

Viraf Vasania is associated with Reliance Life Sciences Pvt. Ltd., where he continues to advance his research and development efforts in the field of ocular health. His dedication to innovation has positioned him as a key figure in the industry.

Collaborations

He collaborates with notable colleagues, including Kishore Reddy and Kashyap Subhadra Devi, to further enhance the impact of his work in ocular tissue engineering.

Conclusion

Viraf Vasania's contributions to the field of ocular tissue engineering through his patented conjunctival tissue system demonstrate his commitment to improving patient outcomes. His innovative work continues to pave the way for advancements in ocular health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…